How Much Did SummerBio Raise?
Funding & Key Investors

SummerBio, a medical diagnostics company, has secured significant enterprise-level funding, with its most recent capital injection amounting to $7.3M. This latest financing round, characterized as a major strategic investment, contributes to the company's overall funding total of $7.3M. The company's trajectory suggests a strong focus on scaling its operations and expanding its market presence in the critical field of medical diagnostics.

What is SummerBio?

SummerBio
Healthcare ServicesMedical Laboratories & Imaging CentersManufacturing

Based out of Los Angeles, CA, SummerBio operates within the medical diagnostics sector, with a particular emphasis on COVID-19 Coronavirus-related solutions. The company's focus on this critical area positions it as a key player in public health response and diagnostic innovation. The substantial enterprise-level funding it has attracted underscores the market's confidence in its technology and strategic direction.

How much funding has SummerBio raised?

SummerBio has raised a total of $7.3M across 1 funding round:

2020

Unspecified

$7.3M

Unspecified (2020): $7.3M with participation from The 8VC, Intel Capital, Capricorn Investment Group, and Toyota AI Ventures LLC

Key Investors in SummerBio

The 8VC

8VC is a venture capital firm known for investing in early-stage companies across various technology sectors. Their involvement suggests a belief in SummerBio's foundational technology and long-term growth potential.

Intel Capital

Intel Capital, the venture investment arm of Intel, focuses on companies in areas like AI, autonomous vehicles, and cloud computing. Their participation indicates a strategic interest in SummerBio's technological advancements and potential integration with broader tech ecosystems.

Capricorn Investment Group

Capricorn Investment Group manages diversified portfolios with a focus on sustainable, climate, and impact investments. Their backing of SummerBio suggests an alignment with the company's mission and its potential to address significant societal challenges through diagnostics.

What's next for SummerBio?

The recent major strategic investment into SummerBio signals a pivotal moment for the company, likely enabling accelerated research and development, expansion of its diagnostic capabilities, and broader market penetration. This influx of capital is expected to fuel further innovation in its COVID-19 Coronavirus diagnostics and potentially diversify its offerings. The company's growth trajectory, supported by this significant backing, points towards an increased capacity to address pressing public health needs and solidify its position in the competitive medical diagnostics landscape.

See full SummerBio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Elderly Care ServicesHealthcare Services
Elderly Care ServicesHealthcare Services
Elderly Care ServicesHealthcare Services
Elderly Care ServicesHealthcare Services

Frequently Asked Questions Regarding SummerBio Financial Insights

What are the most recent funding rounds that SummerBio has completed, and what were the funding rounds?
SummerBio has recently completed 1 funding rounds: Unspecified on Nov 18, 2020.
What is the total amount of funding SummerBio has raised to date?
SummerBio has raised a total of $7.3M in funding to date.
How many funding rounds has SummerBio completed?
SummerBio has completed 1 funding rounds.
How much funding did SummerBio raise in its most recent funding round?
SummerBio raised $7.3M in its most recent funding round.
Who are the lead investors in SummerBio's latest funding round?
The lead investor in SummerBio's latest funding round was The 8VC. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in SummerBio's history?
The largest funding round in SummerBio's history was $7.3M.
See more information about SummerBio